Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients
Open Access
- 19 May 2011
- journal article
- Published by Springer Science and Business Media LLC in Journal of Translational Medicine
- Vol. 9 (1), 70
- https://doi.org/10.1186/1479-5876-9-70
Abstract
Background A limitation of positive selection strategies to enrich for circulating tumor cells (CTCs) is that there might be CTCs with insufficient expression of the surface target marker which may be missed by the procedure. We optimized a method for enrichment, subsequent detection and characterization of CTCs based on depletion of the leukocyte fraction. Methods The 2-step protocol was developed for processing 20 mL blood and based on red blood cell lysis followed by leukocyte depletion. The remaining material was stained with the epithelial markers EpCAM and cytokeratin (CK) 7/8 or for the melanoma marker HMW-MAA/MCSP. CTCs were detected by flow cytometry. CTCs enriched from blood of patients with carcinoma were defined as EpCAM+CK+CD45-. CTCs enriched from blood of patients with melanoma were defined as MCSP+CD45-. One-hundred-sixteen consecutive blood samples from 70 patients with metastatic carcinomas (n = 48) or metastatic melanoma (n = 22) were analyzed. Results CTCs were detected in 47 of 84 blood samples (56%) drawn from carcinoma patients, and in 17 of 32 samples (53%) from melanoma patients. CD45-EpCAM-CK+ was detected in pleural effusion specimens, as well as in peripheral blood samples of patients with NSCLC. EpCAM-CK+ cells have been successfully cultured and passaged longer than six months suggesting their neoplastic origin. This was confirmed by CGH. By defining CTCs in carcinoma patients as CD45-CK+ and/or EpCAM+, the detection rate increased to 73% (61/84). Conclusion Enriching CTCs using CD45 depletion allowed for detection of epithelial cancer cells not displaying the classical phenotype. This potentially leads to a more accurate estimation of the number of CTCs. If detection of CTCs without a classical epithelial phenotype has clinical relevance need to be determined.Keywords
This publication has 44 references indexed in Scilit:
- Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression patternBreast Cancer Research and Treatment, 2010
- Expression of the stem cell marker nestin in peripheral blood of patients with melanomaBritish Journal of Dermatology, 2010
- Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patientsBreast Cancer Research, 2008
- Detection of Mutations inEGFRin Circulating Lung-Cancer CellsThe New England Journal of Medicine, 2008
- The human keratins: biology and pathologyHistochemistry and Cell Biology, 2008
- Phenotypic and Genetic Characterization of Circulating Tumor Cells by Combining Immunomagnetic Selection and FICTION TechniquesJournal of Histochemistry & Cytochemistry, 2008
- Isolation of rare circulating tumour cells in cancer patients by microchip technologyNature, 2007
- The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection methodBreast Cancer Research and Treatment, 2007
- American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast CancerJournal of Clinical Oncology, 2007
- Tumor-Cell Homing to Lymph Nodes and Bone Marrow and CXCR4 Expression in Esophageal CancerJNCI Journal of the National Cancer Institute, 2005